The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Angiotensin-Converting Enzyme Inhibition With Quinapril Improves Endothelial Vasomotor Dysfunction in Patients With Coronary Artery Disease: The TREND (Trial on Reversing ENdothelial Dysfunction) Study
Abstract
Background Angiotensin-converting enzyme (ACE) inhibitors may exert some of their benefits in the therapy of hypertension, congestive heart failure, and acute myocardial infarction by their improvement of endothelial dysfunction. TREND (Trial on Reversing ENdothelial Dysfunction) investigated whether quinapril might improve endothelial dysfunction in normotensive patients with coronary artery disease and no heart failure, cardiomyopathy, or major lipid abnormalities so that confounding variables that affect endothelial dysfunction could be minimized. Methods and Results Using a double-blind, randomized, placebo-controlled design, we measured the effects of quinapril (40 mg daily) on coronary artery diameter responses to acetylcholine using quantitative coronary angiography. The primary response variable was the net change in the acetylcholine-provoked constriction of target segments between the baseline (prerandomization) and 6-month follow-up angiograms. The constrictive responses to acetylcholine were comparable in the placebo (n=54) and quinapril (n=51) groups at baseline. After 6 months, only the quinapril group showed significant net improvement in response to incremental concentrations of acetylcholine (4.5±3.0% [mean±SEM] versus −0.1±2.8% at 10 − 6 mol/L and 12.1±3.0% versus −0.8±2.9% at 10 − 4 mol/L, quinapril versus placebo, respectively; overall P =.002). Conclusions TREND shows that ACE inhibition with quinapril improved endothelial dysfunction in patients who were normotensive and who did not have severe hyperlipidemia or evidence of heart failure. These benefits of ACE inhibition are likely due to attenuation of the contractile effects and superoxide-generating effects of angiotensin II and to enhancement of endothelial cell release of nitric oxide secondary to diminished breakdown of bradykinin.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pfeffer, M. A., Braunwald, E., Moyé, L. A., Basta, L., Brown, E. J., Cuddy, T. E., Davis, B. R., Geltman, E. M., Goldman, S., Flaker, G. C., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271001 · Cited by 5,911
Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells.
Griendling, K. K., Minieri, C. A., Ollerenshaw, J. D., & Alexander, R. W. (1994) · Circulation Research · doi:10.1161/01.res.74.6.1141 · Cited by 2,735
Regulatory Functions of the Vascular Endothelium
Epstein, F. H., Vane, J. R., Änggård, E. E., & Botting, R. M. (1990) · New England Journal of Medicine · doi:10.1056/nejm199007053230106 · Cited by 1,889
Hypercholesterolemia increases endothelial superoxide anion production.
Ohara, Y., Peterson, T. E., & Harrison, D. G. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116491 · Cited by 1,765
Anderson, T. J., Meredith, I. T., Yeung, A. C., Frei, B., Selwyn, A. P., & Ganz, P. (1995) · New England Journal of Medicine · doi:10.1056/nejm199502233320802 · Cited by 1,109
Treasure, C. B., Klein, J. L., Weintraub, W. S., Talley, J. D., Stillabower, M. E., Kosinski, A. S., Zhang, J., Boccuzzi, S. J., Cedarholm, J. C., & Alexander, R. W. (1995) · New England Journal of Medicine · doi:10.1056/nejm199502233320801 · Cited by 1,097
&NA; (1996) · Journal of Occupational & Environmental Medicine · doi:10.1097/00043764-199605000-00005 · Cited by 1,070
Inhibitors of Angiotensin-Converting Enzyme Prevent Myointimal Proliferation After Vascular Injury
Powell, J. S., Clozel, J.-P., Müller, R. K. M., Kuhn, H., Hefti, F., Hosang, M., & Baumgartner, H. R. (1989) · Science · doi:10.1126/science.2526370 · Cited by 1,052
Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall.
Daemen, M. J., Lombardi, D. M., Bosman, F. T., & Schwartz, S. M. (1991) · Circulation Research · doi:10.1161/01.res.68.2.450 · Cited by 737
Yusuf, S., Pepine, C. J., Garces, C., Pouleur, H., Rousseau, M., Salem, D., Kostis, J., Benedict, C., Bourassa, M., & Pitt, B. (1992) · The Lancet · doi:10.1016/0140-6736(92)92889-n · Cited by 666
Self-citationCirculating and tissue angiotensin systems.
Campbell, D. J. (1987) · Journal of Clinical Investigation · doi:10.1172/jci112768 · Cited by 609
The Role of Endothelium in Cardiovascular Homeostasis and Diseases
Rubanyi, G. M. (1993) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199322004-00002 · Cited by 559
Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection.
Lonn, E. M., Yusuf, S., Jha, P., Montague, T. J., Teo, K. K., Benedict, C. R., & Pitt, B. (1994) · Circulation · doi:10.1161/01.cir.90.4.2056 · Cited by 503
Self-citationAtherosclerosis impairs flow-mediated dilation of coronary arteries in humans.
Cox, D. A., Vita, J. A., Treasure, C. B., Fish, R. D., Alexander, R. W., Ganz, P., & Selwyn, A. P. (1989) · Circulation · doi:10.1161/01.cir.80.3.458 · Cited by 414
Antiatherogenic effect of captopril in the Watanabe heritable hyperlipidemic rabbit.
Chobanian, A. V., Haudenschild, C. C., Nickerson, C., & Drago, R. (1990) · Hypertension · doi:10.1161/01.hyp.15.3.327 · Cited by 411
Endothelium-derived contracting factors.
Lüscher, T. F., Boulanger, C. M., Dohi, Y., & Yang, Z. H. (1992) · Hypertension · doi:10.1161/01.hyp.19.2.117 · Cited by 401
Egashira, K., Inou, T., Hirooka, Y., Yamada, A., Maruoka, Y., Kai, H., Sugimachi, M., Suzuki, S., & Takeshita, A. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116183 · Cited by 357
Wiemer, G., Schölkens, B. A., Becker, R. H., & Busse, R. (1991) · Hypertension · doi:10.1161/01.hyp.18.4.558 · Cited by 349
Werns, S. W., Walton, J. A., Hsia, H. H., Nabel, E. G., Sanz, M. L., & Pitt, B. (1989) · Circulation · doi:10.1161/01.cir.79.2.287 · Cited by 322
Self-citationType 1 plasminogen activator inhibitor
三室, 淳. (1990) · Medical Entomology and Zoology · Cited by 266
Harrison, D. G., & Ohara, Y. (1995) · The American Journal of Cardiology · doi:10.1016/0002-9149(95)80018-n · Cited by 163
St Cyres lecture. Endothelium in control.
Henderson, A. H. (1991) · Heart · doi:10.1136/hrt.65.3.116 · Cited by 161
Endothelial dysfunction in atherosclerosis
Harrison, D. G. (1994) · Steinkopff eBooks · doi:10.1007/978-3-642-85660-0_8 · Cited by 145
Induction of the Proto-Oncogene c- jun by Angiotensin II
Naftilan, A. J., Gilliland, G., Eldridge, C. S., & Kraft, A. S. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.10.5536 · Cited by 142
1989 Corcoran lecture: adaptive and maladaptive responses of the arterial wall to hypertension.
Chobanian, A. V. (1990) · Hypertension · doi:10.1161/01.hyp.15.6.666 · Cited by 139
Kawaguchi, H., Sawa, H., & Yasuda, H. (1990) · Journal of Molecular and Cellular Cardiology · doi:10.1016/0022-2828(90)90115-i · Cited by 115
Comparative studies of tissue inhibition by angiotensin converting enzyme inhibitors.
Johnston, C. I., Fabris, B., Yamada, H., Mendelsohn, F. A. O., Cubela, R. B., Sivell, D., & Jackson, B. (1989) · PubMed · Cited by 102
Gibson, C. M., Sándor, T., Stone, P. H., Pasternak, R. C., ROSNER, B. A., & Sacks, F. M. (1992) · The American Journal of Cardiology · doi:10.1016/0002-9149(92)91222-p · Cited by 92
Preservation of Endothelial Function by Ramipril in Rabbits on a Long-Term Atherogenic Diet
Becker, R. H. A., Wiemer, G., & Linz, W. (1991) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199100182-00023 · Cited by 89
Effect of angiotensin II on macrophage functions.
Fóris, G., Dezsö, B., MEDGYESI, G. A., & Füst, G. (1983) · PubMed · Cited by 73
Endothelium Dysfunction in the Coronary Circulation
Lüscher, T. F., & Noll, G. (1994) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199406243-00003 · Cited by 54
Dzau, V. J. (1988) · PubMed · Cited by 53
ANGIOTENSIN CONVERTING ENZYME IN THE RAT HEART: STUDIES OF ITS INHIBITION IN VITRO AND EX VIVO
Fabris, B., Jackson, B., Cubela, R. B., Mendelsohn, F. A. O., & Johnston, C. I. (1989) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1989.tb01563.x · Cited by 42
Texter, M. J., Lees, R. S., Pitt, B., Dinsmore, R. E., & Uprichard, A. C. G. (1993) · Cardiovascular Drugs and Therapy · doi:10.1007/bf00878518 · Cited by 39
Self-citationBrown, M. B. (1992) · Controlled Clinical Trials · doi:10.1016/0197-2456(92)90004-j · Cited by 25
Coronary endothelial vasodilator dysfunction: clinical relevance and therapeutic implications.
Zeiher, A. M., & Schächinger, V. (1994) · PubMed · Cited by 24
Endothelium control of vascular tone and growth: Potential role in coronary artery disease
Lüscher, T. F. (1994) · Developments in cardiovascular medicine · doi:10.1007/978-94-011-1172-0_1 · Cited by 2
Cited by
Nitric oxide synthases: regulation and function
Forstermann, U., & Sessa, W. C. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehr304 · Cited by 4,409
Endothelial Function and Dysfunction: Testing and Clinical Relevance
Deanfield, J. E., Halcox, J. P., & Rabelink, T. J. (2007) · Circulation · doi:10.1161/circulationaha.106.652859 · Cited by 2,710
Endothelial Dysfunction: A Marker of Atherosclerotic Risk
Bonetti, P. O., Lerman, L. O., & Lerman, A. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000051384.43104.fc · Cited by 2,200
Heitzer, T., Schlinzig, T., Krohn, K., Meinertz, T., & Münzel, T. (2001) · Circulation · doi:10.1161/hc4601.099485 · Cited by 1,961
The clinical implications of endothelial dysfunction
Widlansky, M. E., Gokce, N., Keaney, J. F., & Vita, J. A. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00994-x · Cited by 1,749
Metadata
- Authors
- Mancini, G. B. J., Henry, G. C., Macaya, C., O'Neill, B. J., Pucillo, A. L., Carere, R. G., Wargovich, T. J., Mudra, H., Lu¨scher, T. F., Klibaner, M. I., Haber, H. E., Uprichard, A. C. G., Pepine, C. J., & Pitt, B.
- Venue
- Circulation
- Published
- 1996-08
- Volume
- 94
- Issue
- 3
- Pages
- 258-265
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2617392052
- Cited by
- 1,057
- References
- 37
- FWCI
- 44.12
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.